Navarrete C, Alonso A, Awad J, McCloskey D, Ganesan T S, Amess J, Lister T A, Festenstein H
J Immunogenet. 1986 Apr-Jun;13(2-3):77-84. doi: 10.1111/j.1744-313x.1986.tb01087.x.
HLA-A,B,C and DR antigen frequencies were determined in a group of 188 patients suffering from acute myeloid (AML) and acute lymphoid leukaemia (ALL). These antigen frequencies were compared with those obtained on a panel of normal individuals (n = 109) of the same ethnic origin. The significance of the differences in the antigen distribution and the strength of the associations between particular HLA antigens and the disease were then calculated. The results obtained show a decreased frequency of HLA-Aw19 in the overall group of patients and the group of patients with ALL. In addition, the antigen frequency of the HLA-B18 and DR5(DRw11) antigens was also decreased in the overall group of patients and in those patients with AML but not in the patients with ALL. The results suggest that the antigen Aw19 may confer some degree of resistance to the development of ALL and that the HLA-B18 and/or DR5 antigens may be resistance factors for the development of AML.
测定了188例急性髓性白血病(AML)和急性淋巴细胞白血病(ALL)患者的HLA - A、B、C和DR抗原频率。将这些抗原频率与一组相同种族来源的正常个体(n = 109)的抗原频率进行比较。然后计算抗原分布差异的显著性以及特定HLA抗原与疾病之间关联的强度。所得结果显示,在所有患者的总体组以及ALL患者组中,HLA - Aw19的频率降低。此外,在所有患者的总体组以及AML患者中,HLA - B18和DR5(DRw11)抗原的频率也降低,但在ALL患者中未降低。结果表明,抗原Aw19可能赋予对ALL发生的某种程度的抗性,并且HLA - B18和/或DR5抗原可能是AML发生的抗性因素。